Illumina, Inc. (ILMN)
207.03
-2.52
(-1.20%)
USD |
NASDAQ |
Nov 13, 16:00
207.03
0.00 (0.00%)
After-Hours: 19:59
Illumina EPS Diluted (Quarterly) : 1.429 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.429 |
| June 30, 2026 | 1.353 |
| March 31, 2026 | 0.8701 |
| December 31, 2025 | 2.169 |
| September 30, 2025 | 0.974 |
| June 30, 2025 | 1.497 |
| March 31, 2025 | 0.8239 |
| December 31, 2024 | 1.169 |
| September 30, 2024 | 4.406 |
| June 30, 2024 | -12.50 |
| March 31, 2024 | -0.7924 |
| December 31, 2023 | -1.107 |
| September 30, 2023 | -4.772 |
| June 30, 2023 | -1.481 |
| March 31, 2023 | 0.019 |
| December 31, 2022 | -0.8861 |
| September 30, 2022 | -24.31 |
| June 30, 2022 | -3.408 |
| March 31, 2022 | 0.5409 |
| December 31, 2021 | 0.7134 |
| September 30, 2021 | 2.072 |
| June 30, 2021 | 1.258 |
| March 31, 2021 | 1.00 |
| December 31, 2020 | 1.748 |
| September 30, 2020 | 1.210 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.3176 |
| March 31, 2020 | 1.169 |
| December 31, 2019 | 1.615 |
| September 30, 2019 | 1.581 |
| June 30, 2019 | 1.987 |
| March 31, 2019 | 1.564 |
| December 31, 2018 | 1.41 |
| September 30, 2018 | 1.336 |
| June 30, 2018 | 1.41 |
| March 31, 2018 | 1.41 |
| December 31, 2017 | 0.46 |
| September 30, 2017 | 1.101 |
| June 30, 2017 | 0.87 |
| March 31, 2017 | 2.490 |
| December 31, 2016 | 0.84 |
| September 30, 2016 | 0.87 |
| June 30, 2016 | 0.82 |
| March 31, 2016 | 0.60 |
| December 31, 2015 | 0.70 |
| September 30, 2015 | 0.79 |
| June 30, 2015 | 0.69 |
| March 31, 2015 | 0.92 |
| December 31, 2014 | 1.03 |
| September 30, 2014 | 0.63 |
| June 30, 2014 | 0.31 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Thermo Fisher Scientific, Inc. | 4.639 |
| Bio-Rad Laboratories, Inc. | 17.02 |
| Danaher Corp. | 1.747 |
| QIAGEN NV | 0.5078 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 220.00M |
| Revenue (Quarterly) | 1.13B |
| Total Expenses (Quarterly) | 910.00M |
| Enterprise Value | 32.83B |
| Gross Profit Margin (Quarterly) | 73.54% |
| Profit Margin (Quarterly) | 19.47% |
| Earnings Yield | 2.81% |
| Operating Earnings Yield | 2.96% |
| Normalized Earnings Yield | 2.460 |